Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 11 - 04 tags : Therapy save search
Precision BioSciences Announces Two Oral Presentations Highlighting Updated Interim Data from Lead PBCAR0191 CAR T Immunotherapy
Published: 2021-11-04 (Crawled : 02:00) - biospace.com/
DTIL | $9.86 -8.02% 140K
|
Health Technology
|
| O: 1.0%
H: 0.0%
C: 0.0%
presentation immunotherapy therapy car-t bioscience
Gilead and Kite Oncology Demonstrate Broad Leadership in Cell Therapy and Expanding Blood Cancer Pipeline
Published: 2021-11-04 (Crawled : 21:00) - biospace.com/
GILD | News | $66.45 0.44% 4.3M
|
Health Technology
|
| O: -0.43%
H: 0.04%
C: -0.97%
blood therapy cancer
Athletico Physical Therapy Opens in Dallas-Park Cities
Published: 2021-11-04 (Crawled : 16:00) - prnewswire.com
FNCTF | News | $11.0354 320
|
Communications
| Email alert
Add to watchlist
therapy
Cellenkos® Inc. Secures $15 Million Series A Financing to Accelerate the Development of Transformation Cell-Based Therapies
Published: 2021-11-04 (Crawled : 14:15) - prnewswire.com
INCY | $52.07 -1.42% 800K
|
Health Technology
|
| O: 2.41%
H: 0.0%
C: 0.0%
therapy
Gracell Biotechnologies to Present Preclinical Results of TruUCAR-enabled CD19/CD7 Dual-Directed Allogeneic CAR-T Cell Therapy (GC502) for B-Cell Malignancies at the 63rd ASH Annual Meeting
Published: 2021-11-04 (Crawled : 13:00) - prnewswire.com
GRCL | $10.25 -0.29% 6.4M
|
Manufacturing
| Email alert
Add to watchlist
therapy car-t results biotech iot preclinical t-cell pre-clinical
Actinium Announces Completion of Enrollment of Actimab-A CLAG-M Combination Trial in Patients with Relapsed or Refractory Acute Myeloid Leukemia Fit for Induction Therapy
Published: 2021-11-04 (Crawled : 13:00) - prnewswire.com
ATNM | $6.72 0.75% 220K
|
Health Technology
|
| O: 7.4%
H: 0.77%
C: -7.99%
myeloid leukemia therapy leukemia trial enroll acute myeloid leukemia
The Importance of Trust in a Cell and Gene Therapy (CGT) CDMO Relationship
Published: 2021-11-04 (Crawled : 13:00) - thermogenesis.com
THMO | $0.6695 3.0% 8.5K
|
Health Technology
|
| O: 1.25%
H: 1.23%
C: 0.0%
gene therapy therapy cel
2seventy bio Completes Spin Transaction and Launches Innovative Immuno-oncology Cell Therapy Company
Published: 2021-11-04 (Crawled : 12:00) - biospace.com/
JNJ | News | $147.895 1.48% 5.8M
|
Health Technology
|
| O: -0.13%
H: 0.0%
C: 0.0%
BLUE | $0.9729 2.09% 6.5M
|
Health Technology
|
| O: 0.24%
H: 0.0%
C: 0.0%
therapy
Innovent Announces NMPA Acceptance of a Supplemental New Drug Application for Sintilimab in Combination with Chemotherapy as First-Line Treatment for Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Published: 2021-11-04 (Crawled : 09:00) - prnewswire.com
LLY | $727.48 -2.48% 2M
|
Health Technology
|
| O: 3.16%
H: 0.0%
C: 0.0%
INCY | $52.07 -1.42% 800K
|
Health Technology
|
| O: 2.41%
H: 0.0%
C: 0.0%
new drug treatment application therapy drug
Gainers vs Losers
| 70% | 30% |
Top 10 Gainers
AGBA | News | $1.305 226.25% 130M
|
Finance
EGOX | $0.0503 39.72% 320M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
NVFY | $2.65 25.59% 33M
|
Consumer Durables
INDO | $5.1 25.0% 15M
|
Energy Minerals
AULT | $0.2998 23.83% 53M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.